E-Liquid clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Evaluating the Comparative Pharmacokinetics of Nicotine After Administration Via JUUL or Tobacco Cigarettes
open to eligible people ages 21-70
This is an observational, crossover design that will examine the pharmacokinetics and pharmacodynamics of impact of smoking tobacco cigarettes or vaping the JUUL electronic cigarette.
at UCSF
Our lead scientists for E-Liquid research studies include Neal L Benowitz, MD.
Last updated: